CSL Limited

Company Profile

CSL Limited had its IPO on under the ticker symbol CMXHF.

The company operates in the Healthcare sector and Biotechnology industry. CSL Limited has a staff strength of 30,000 employees.

Stock update

Shares of CSL Limited opened at $174.18 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $174.18 - $174.18, and closed at $174.18.

This is a +0.75% increase from the previous day's closing price.

A total volume of 7,500 shares were traded at the close of the day’s session.

In the last one week, shares of CSL Limited have increased by +1.32%.

CSL Limited's Key Ratios

CSL Limited has a market cap of $97.80 billion, indicating a price to book ratio of 6.6463 and a price to sales ratio of 9.304.

In the last 12-months CSL Limited’s revenue was $11.70 billion with a gross profit of $5.73 billion and an EBITDA of $3.45 billion. The EBITDA ratio measures CSL Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, CSL Limited’s operating margin was 25.39% while its return on assets stood at 6.31% with a return of equity of 13.38%.

In Q2, CSL Limited’s quarterly earnings growth was a negative -12.5% while revenue growth was a positive 18.9%.

CSL Limited’s PE and PEG Ratio

Forward PE

43.1034

Trailing PE

45.6916

PEG

0

Its diluted EPS in the last 12-months stands at $4.41 per share while it has a forward price to earnings multiple of 43.1034 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into CSL Limited’s profitability.

CSL Limited stock is trading at a EV to sales ratio of 9.2104 and a EV to EBITDA ratio of 27.8928. Its price to sales ratio in the trailing 12-months stood at 9.304.

CSL Limited stock pays annual dividends of $2.25 per share, indicating a yield of 1.14% and a payout ratio of 51.57%.

Balance sheet and cash flow metrics

Total Assets

$28.35 billion

Total Liabilities

$7.11 billion

Operating Cash Flow

$-541350000.00

Capital Expenditure

$276.90 million

Dividend Payout Ratio

51.57%

CSL Limited ended 2024 with $28.35 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $28.35 billion while shareholder equity stood at $14.58 billion.

CSL Limited ended 2024 with $0 in deferred long-term liabilities, $7.11 billion in other current liabilities, 4988400000.00 in common stock, $13.50 billion in retained earnings and $1.19 billion in goodwill. Its cash balance stood at $10.44 billion and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $3.86 billion.

CSL Limited’s total current assets stands at $16.46 billion while long-term investments were $402.90 million and short-term investments were $0. Its net receivables were $1.51 billion compared to accounts payable of $591.80 million and inventory worth $4.33 billion.

In 2024, CSL Limited's operating cash flow was $-541350000.00 while its capital expenditure stood at $276.90 million.

Comparatively, CSL Limited paid $0.52 in dividends in 2024.

Other key metrics

Current Trading Price

$174.18

52-Week High

$216.6198

52-Week Low

$166.2925

Analyst Target Price

$

CSL Limited stock is currently trading at $174.18 per share. It touched a 52-week high of $216.6198 and a 52-week low of $216.6198. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $179.53 and 200-day moving average was $190.23 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 40.5% of the company’s stock are held by insiders while 3500.3% are held by institutions.